42 related articles for article (PubMed ID: 21594538)
1. Proliferating cell nuclear antigen expression and the progression of cervical intraepithelial neoplasia.
Lakshmi S; Nair M; Rajalakshmi T; Jayaprakash P; Nair M; Pillai M
Oncol Rep; 1996 Nov; 3(6):1195-8. PubMed ID: 21594538
[TBL] [Abstract][Full Text] [Related]
2. Proliferating cell nuclear antigen immunoreactivity in cervical intraepithelial neoplasia and benign cervical epithelium.
Shurbaji MS; Brooks SK; Thurmond TS
Am J Clin Pathol; 1993 Jul; 100(1):22-6. PubMed ID: 8102221
[TBL] [Abstract][Full Text] [Related]
3. Tumor proliferative compartment in non-Hodgkin's lymphoma.
Radhakrishnan R; Gangadharan V; Nair M; Pillai M
Oncol Rep; 1997; 4(3):641-4. PubMed ID: 21590115
[TBL] [Abstract][Full Text] [Related]
4. Expression of the proliferating cell nuclear antigen in cervical neoplasia.
Raju GC
Int J Gynecol Pathol; 1994 Oct; 13(4):337-41. PubMed ID: 7814195
[TBL] [Abstract][Full Text] [Related]
5. Expression of proliferating cell nuclear antigen in premalignant lesions of the larynx.
Zhao R; Hirano M; Kurita S
Am J Otolaryngol; 1996; 17(1):36-44. PubMed ID: 8801814
[TBL] [Abstract][Full Text] [Related]
6. Sequential increases in proliferating cell nuclear antigen expression in head and neck tumorigenesis: a potential biomarker.
Shin DM; Voravud N; Ro JY; Lee JS; Hong WK; Hittelman WN
J Natl Cancer Inst; 1993 Jun; 85(12):971-8. PubMed ID: 8098774
[TBL] [Abstract][Full Text] [Related]
7. MIB 1 immunostaining in cervical intraepithelial neoplasia: prognostic significance in mild and moderate lesions.
Garzetti GG; Ciavattini A; De Nictolis M; Lucarini G; Goteri G; Romanini C; Biagini G
Gynecol Obstet Invest; 1996; 42(4):261-6. PubMed ID: 8979100
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical expression of metallothionein in benign premalignant and malignant epithelium of the larynx: correlation with p53 and proliferative cell nuclear antigen.
Ioachim E; Assimakopoulos D; Peschos D; Zissi A; Skevas A; Agnantis NJ
Pathol Res Pract; 1999; 195(12):809-14. PubMed ID: 10631715
[TBL] [Abstract][Full Text] [Related]
9. Cytometric evidence that cervical intraepithelial neoplasia I and II are dysplasias rather than true neoplasias. An image analysis study of factors involved in the progression of cervical lesions.
Mariuzzi G; Santinelli A; Valli M; Sisti S; Montironi R; Mariuzzi L; Alberti R; Pisani E
Anal Quant Cytol Histol; 1992 Apr; 14(2):137-47. PubMed ID: 1590897
[TBL] [Abstract][Full Text] [Related]
10. Glycoprotein CD44 expression in benign, premalignant and malignant epithelial lesions of the larynx: an immunohistochemical study including correlation with Rb, p53, Ki-67 and PCNA.
Ioachim E; Assimakopoulos D; Goussia AC; Peschos D; Skevas A; Agnantis NJ
Histol Histopathol; 1999 Oct; 14(4):1113-8. PubMed ID: 10506927
[TBL] [Abstract][Full Text] [Related]
11. [Comparative study of HPV infection and proliferating cell nuclear antigen of uterine cervix].
Murakami T; Nagai N; Ota S; Ohama K
Nihon Sanka Fujinka Gakkai Zasshi; 1993 Sep; 45(9):967-72. PubMed ID: 8103785
[TBL] [Abstract][Full Text] [Related]
12. Comparative Analysis of Cluster of Differentiation 57 and Proliferating Cell Nuclear Antigen Expression in Different Grades of Oral Squamous Cell Carcinoma: An Immunohistochemical Study.
Cs AS; Joseph TI; Girish KL; T P; Binu A; Mary J
Cureus; 2023 Sep; 15(9):e44779. PubMed ID: 37809121
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical Expression of Cell Proliferating Nuclear Antigen (PCNA) and p53 Protein in Cervical Cancer.
Madhumati G; Kavita S; Anju M; Uma S; Raj M
J Obstet Gynaecol India; 2012 Oct; 62(5):557-61. PubMed ID: 24082558
[TBL] [Abstract][Full Text] [Related]
14. The expression of proliferating cell nuclear antigen in hepatocellular carcinoma.
Wu JD; Tseng HH
Zhonghua Yi Xue Za Zhi (Taipei); 1994 Apr; 53(4):198-203. PubMed ID: 7911731
[TBL] [Abstract][Full Text] [Related]
15. Expression of cell-cycle proteins p53, p21 (WAF-1), PCNA and Ki-67 in benign, premalignant and malignant skin lesions with implicated HPV involvement.
Lu S; Tiekso J; Hietanen S; Syrjänen K; Havu VK; Syrjänen S
Acta Derm Venereol; 1999 Jul; 79(4):268-73. PubMed ID: 10429981
[TBL] [Abstract][Full Text] [Related]
16. Proliferating cell nuclear antigen (PCNA) as a marker of dysplasia in oral mucosa.
Martínez-Lara I; González-Moles MA; Ruiz-Avila I; Bravo M; Ramos MC; Fernández-Martínez JA
Acta Stomatol Belg; 1996 Mar; 93(1):29-32. PubMed ID: 8986050
[TBL] [Abstract][Full Text] [Related]
17. [Proliferating cell nuclear antigen in cervical cancer and precursor lesions].
Wistuba I; Roa I; Araya JC; Villaseca M; Capurro I; Chávez F
Rev Med Chil; 1995 Sep; 123(9):1077-83. PubMed ID: 8728730
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of proliferative activity of ovarian carcinoma as revealed by PCNA and AgNOR analyses.
Ghazizadeh M; Sasaki Y; Araki T; Konishi H; Aihara K
Am J Clin Pathol; 1997 Apr; 107(4):451-8. PubMed ID: 9124214
[TBL] [Abstract][Full Text] [Related]
19. The assessment of proliferating cell nuclear antigen (PCNA) immunostaining in the uterine cervix and cervical squamous neoplasia.
Al-Nafussi AI; Klys HS; Rebello G; Kelly C; Kerr G; Cowie V
Int J Gynecol Cancer; 1993 May; 3(3):154-158. PubMed ID: 11578336
[TBL] [Abstract][Full Text] [Related]
20. Immunoreactive MUC1 expression at the deepest invasive portion correlates with prognosis of colorectal cancer.
Hiraga Y; Tanaka S; Haruma K; Yoshihara M; Sumii K; Kajiyama G; Shimamoto F; Kohno N
Oncology; 1998; 55(4):307-19. PubMed ID: 9663420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
